Business Description
Amplia Therapeutics Ltd
ISIN : AU0000023822
Description
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.13 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.37 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 17.4 | |||||
| 3-Year FCF Growth Rate | 4.7 | |||||
| 3-Year Book Growth Rate | -14.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.39 | |||||
| 9-Day RSI | 33.87 | |||||
| 14-Day RSI | 41.4 | |||||
| 6-1 Month Momentum % | 262.5 | |||||
| 12-1 Month Momentum % | 180.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.98 | |||||
| Quick Ratio | 1.98 | |||||
| Cash Ratio | 0.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -21.1 | |||||
| Shareholder Yield % | -0.13 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -32.16 | |||||
| ROA % | -26.44 | |||||
| ROIC % | -85.94 | |||||
| 3-Year ROIIC % | -424.48 | |||||
| ROC (Joel Greenblatt) % | -365 | |||||
| ROCE % | -31.47 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.1 | |||||
| Price-to-Tangible-Book | 8.4 | |||||
| EV-to-EBIT | -9.49 | |||||
| EV-to-EBITDA | -9.67 | |||||
| EV-to-FCF | -7.96 | |||||
| Price-to-Net-Current-Asset-Value | 8.4 | |||||
| Earnings Yield (Greenblatt) % | -10.54 | |||||
| FCF Yield % | -15.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:INNMF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Amplia Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.015 | ||
| Beta | 0.04 | ||
| Volatility % | 147.94 | ||
| 14-Day RSI | 41.4 | ||
| 14-Day ATR ($) | 0.010484 | ||
| 20-Day SMA ($) | 0.110374 | ||
| 12-1 Month Momentum % | 180.46 | ||
| 52-Week Range ($) | 0.025 - 0.155 | ||
| Shares Outstanding (Mil) | 274.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Amplia Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Amplia Therapeutics Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Amplia Therapeutics Ltd Frequently Asked Questions
What is Amplia Therapeutics Ltd(INNMF)'s stock price today?
The current price of INNMF is $0.08. The 52 week high of INNMF is $0.16 and 52 week low is $0.03.
When is next earnings date of Amplia Therapeutics Ltd(INNMF)?
The next earnings date of Amplia Therapeutics Ltd(INNMF) is .
Does Amplia Therapeutics Ltd(INNMF) pay dividends? If so, how much?
Amplia Therapeutics Ltd(INNMF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers